Pathophysiology of chronic limb ischemia.

Area of Science:

• Vascular Surgery
• Cardiovascular Research
• Pathophysiology

Background:

• Chronic ischemia of lower extremities, particularly critical limb ischemia (CLI), is a growing concern in vascular surgery, affecting 3% of German hospitalizations.
• Peripheral artery disease (PAD) progression involves endothelial dysfunction triggered by factors like hyperlipidemia and hypertension, leading to immune cell infiltration and plaque destabilization.
• Vessel wall thickening and hypoxia-induced factor (HIF-1α) activation promote angiogenesis, but often inadequately compensate for arterial stenosis.

Purpose of the Study:

• To elucidate the pathophysiological mechanisms underlying chronic limb ischemia in peripheral artery disease.
• To detail the cellular and molecular events contributing to vascular wall changes and hypoxia.
• To understand the limitations of angiogenesis and arteriogenesis in compensating for arterial stenosis.

Main Methods:

• Review of pathophysiological processes in chronic limb ischemia.
• Analysis of cellular mechanisms including immune cell migration and smooth muscle cell phenotype changes.
• Examination of molecular pathways such as HIF-1α and VEGF in response to hypoxia.
• Evaluation of compensatory vascular mechanisms like angiogenesis and arteriogenesis.

Main Results:

• Stress factors initiate endothelial dysfunction, increasing vascular permeability and attracting immune cells.
• Immune cells contribute to matrix degradation and plaque destabilization, with smooth muscle cells and macrophages adopting osteoclast-like phenotypes.
• Hypoxia intensifies HIF-1α, increasing VEGF and promoting angiogenesis, yet this is insufficient to overcome stenosed arteries.
• Arteriogenesis, driven by pressure gradients and shear forces, can be overwhelmed by progressive stenosis, leading to tissue hypoxia and atrophy.

Conclusions:

• Chronic limb ischemia involves a complex interplay of endothelial dysfunction, inflammation, vascular remodeling, and hypoxia.
• Current angiogenic and arteriogenic capacities are often insufficient to counteract the progression of peripheral artery disease.
• Further research into enhancing vascular compensation mechanisms is critical for managing critical limb ischemia and preventing tissue loss.